Linszen, D.

patient cannabi study psychiatry cannabis use schizophrenia disorder effect control risperidone sample olanzapine group psychosi university association department netherland treatment symptom y-boc interaction research result analysis schizophrenia m rietschel germany score replication allele health ambra 1 genetic genotype table 2008 lippincott williams centre winkel region ambra lifetime outcome evidence variation institute measure genome-wide akt 1 eli lilly 6 weeks information performance van winkel imaging cognition onset investigator center medication analyses cidi lifetime use imaging genetics study change information patients genome-wide association study baseline follow-up alteration antipsychotic figure j psychiatry chromosome individual 0.18 cannabis-induced urinalysi y-bocs scores finding denmark j clin psychiatry